07June

Another Challenge For David

June 07, 2021
0 Comment

He planned to cycle 1000km in thirty days in the heat and humidity of Singapore to raise money for Secondary1st.  In the first two days he covered more than 80 km so he was well

Read more
07June

Good Results From Parp Inhibitor Trial

June 07, 2021
0 Comment

A drug trial for Olaparib, also known as Lynparza, has shown good results for women with breast cancer who have faulty variants in BRCA1 or BRCA2 genes.  In the trial 85.9% of women given Olaparib

Read more
24May

A New Challenge for David

May 24, 2021
0 Comment

In 2017 David cycled all the way from London to Amsterdam to raise money for Secondary1st.  He had recently lost his wife Joanne to secondary breast cancer and Secondary1st was a charity which had been

Read more
20April

The 10.500 mile Challenge

April 20, 2021
0 Comment

JH Mechanical Services are most generously continuing to raise funds for Secondary1st as their chosen charity. From the beginning of April to the end of October each member of their team will take on the

Read more
20April

Tim did it

April 20, 2021
0 Comment

The sun was shining in a clear blue sky when Tim jumped... out of a plane 3 miles up.  It had taken about 12 minutes for the Cessna Super Cargomaster to climb to the correct

Read more
07April

More Challenges for Tracey

April 07, 2021
0 Comment

Tracey started 2020 with plans to take part in a number of events to raise more money for Secondary1st.  She completed the 50km Winter Walk in London and was training for the 50km Easter Walk

Read more
07April

Up in the Air

April 07, 2021
0 Comment

Tim is planning to do something he’s never done before to raise funds for Secondary1st and increase awareness of secondary breast cancer; he’s going to skydive 10,000 feet from a plane.  It will take about

Read more
07April

A More Efficient Treatment Method

April 07, 2021
0 Comment

The NHS in England is introducing a more efficient way of administering a treatment for HER2 positive early and metastatic breast cancer.  The new treatment is called Phesgo and is a combination of Perjeta (pertuzumab)

Read more
01March

A Nice recommendation

March 01, 2021
0 Comment

Nice, the National Institute for Health and Care Excellence, has recommended the use of ribociclib, also known as Kisqali for routine use by the NHS in England and Wales, after it was originally made available

Read more
19February

A video message from Dr Seth Coffelt

February 19, 2021
0 Comment

Dr Coffelt and his team at the Beatson Institute of the University of Glasgow are investigating the role of a type of immune cell called gamma delta T cells in helping breast cancer spread through

Read more